0
0

Department of Veterans Affairs Awarded a Contract to ACADIA PHARMACEUTICALS INC for $330,000,000.00

Signed on

9/25/2023, 12:00 AM

ACADIA PHARMACEUTICALS INC Government Contract #36F79723D0237

ACADIA PHARMACEUTICALS INC was awarded a contract with the United States Government for $330,000,000.00. The contract was awarded by the agency office NAC FEDERAL SUPPLY SCHEDULE (36F797), which is a division with the Department of Veterans Affairs within the Department of Veterans Affairs.

Summary of Award

Acadia Pharmaceuticals Inc, a U.S.-owned business based in San Diego, California, received a federal contract worth $330,000,000 from the Department of Veterans Affairs. The contract, signed on September 25, 2023, is for pharmaceutical products and biologicals. Notable details include the use of negotiated proposal/quote solicitation procedures, full and open competition, and fixed-price with economic price adjustment contract pricing. The contract spans from October 1, 2023, to September 30, 2028, with spending focused on drugs, pharmaceuticals, and hematology related products. Total obligations and outlays are currently at $0.

Contract Details

Contract ID36F79723D0237
Contract TypeIDV_C
Total Obligation$0.00
Exercised Options
Base Amount + Options$330,000,000.00
Date Signed2023-09-25
Contract Description65 I B, DRUGS, PHARMACEUTICALS, & HEMATOLOGY RELATED PRODUCTS, FSS CONTRACT AWARD
Start Date2023-10-01
End Date2028-09-30

Agency Details

Awarding AgencyDepartment of Veterans Affairs
Awarding Sub AgencyDepartment of Veterans Affairs
Awarding OfficeNAC FEDERAL SUPPLY SCHEDULE (36F797)
Funding AgencyDepartment of Veterans Affairs
Funding Sub AgencyDepartment of Veterans Affairs
Funding OfficeNAC FEDERAL SUPPLY SCHEDULE (36F797)

Recipient Details

RecipientACADIA PHARMACEUTICALS INC
Recipient Location12830 EL CAMINO REAL SAN DIEGO CALIFORNIA, UNITED STATES
Business CategoriesCategory Business, Corporate Entity Not Tax Exempt, Self-Certified Small Disadvantaged Business, Small Business, Special Designations, U.S.-Owned Business

Comments

Award Transactions